INTRACOASTAL CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (PCSA)

Filing Manager
INTRACOASTAL CAPITAL, LLC
Reporting Manager
Mitchell P. Kopin
Security
Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share
Symbol
PCSA
Shares outstanding
2,469,136 shares
Disclosed Ownership
200,000 shares
Ownership
8.1%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:45:21 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Quoteable Key Fact

"INTRACOASTAL CAPITAL, LLC disclosed 8.1% ownership in Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (PCSA) on 31 Dec 2025."

Quick Takeaways

  • INTRACOASTAL CAPITAL, LLC filed SCHEDULE 13G/A for Processa Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (PCSA).
  • Disclosed ownership: 8.1%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2026, 16:45.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Mitchell P. Kopin 8.1% 200,000 0 200,000 /s/ Mitchell P. Kopin Mitchell P. Kopin
Daniel B. Asher 8.1% 200,000 0 200,000 /s/ Daniel B. Asher Daniel B. Asher
Intracoastal Capital LLC 8.1% 200,000 0 200,000 /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager